Catalog Number TVTS4 |
Device Problem
Migration or Expulsion of Device (1395)
|
Patient Problems
Erosion (1750); Pain (1994); Not Applicable (3189); No Code Available (3191)
|
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.(b)(4).
|
|
Event Description
|
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2008 and the mesh was implanted.Following the procedure, the patient experienced a mesh erosion and underwent a mesh excision on (b)(6) 2013.No additional information was provided.
|
|
Manufacturer Narrative
|
Date sent to the fda: 06/28/2017
ethicon mdr summary reporting (b)(4)
reporting period (b)(6) 2017
supplemental 01 - attachment: [(b)(6) -2017 pah supplemental 01.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4), reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037
reporting period (b)(4) 2017 through (b)(4) 2017.Supplemental 07 - attachment: [(b)(4) 2017 supplemental (b)(4)].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037
reporting period (b)(4) 2017 through (b)(4) 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 4/23/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 6/25/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/19/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 02/18/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/19/2021.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2017 through march 31, 2017.
|
|
Manufacturer Narrative
|
Date sent to fda: 06/18/2021.
|
|
Search Alerts/Recalls
|